Protective roles of mast cells and mast cell-derived TNF in murine malaria

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 3294-3302

  Furuta, Takahisa ^a   Kikuchi, Takane ^a,c   Iwakura, Yoichiro ^a   Watanabe, Naohiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPOUND 48-80; IMMUNOGLOBULIN E ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED MAST CELL; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DEATH; DISEASE MODEL; MALARIA; MALE; MAST CELL; MOUSE STRAIN; NONHUMAN; PARASITEMIA; PATHOGENESIS; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTECTION; RAT; SPLENOMEGALY;

EID: 33747767880     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.3294     Document Type: Article

References (53)

1. Trigg, P. I., and A. V. Kondrachine. 1998. Parasite biology, pathogenesis, and protection. In Malaria. I. W. Sherman, ed. Am. Soc. Microbiol., Washington DC, pp. 11-22.
2. Gordon, J. R., and S. J. Galli. 1991. Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI: a mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174: 103-107.
3. Mordmuller, B. G., W. G. Metzger, P. Juillard, B. M. Brinkman, C. L. Verweij, G. E. Grau, and P. G. Kremsner. 1997. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur. Cytokine Network 8: 29-35.
4. McGregor, I. A. 1987. Thoughts on malaria in pregnancy with consideration of some factors which influence remedial strategies. Parassitologia 29: 153-162.
5. Butcher, G. A., T. Garland, A. B. Ajdukiewicz, and I. A. Clark. 1990. Serum tumor necrosis factor associated with malaria in patients in the Solomon Islands. Trans. R. Soc. Trop. Med. Hyg. 84: 658-661.
6. Clark, I. A., and K. A. Rockett. 1996. Nitric oxide and parasitic disease. Adv. Parasitol. 37: 1-56.
7. Friedland, J. S., M. Ho, D. G. Remick, D. Bunnag, N. J. White, and G. E. Griffin. 1993. Interleukin-8 and Plasmodium falciparum malaria in Thailand. Trans. R. Soc. Trop. Med. Hyg. 87: 54-55.
8. Grau, G. E., T. E. Taylor, M. E. Molyneux, J. J. Wirima, P. Vassalli, M. Hommel, and P. H. Lambert. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320: 1586-1591.
9. Ho, M., T. Schollaardt, S. Snape, S. Looareesuwan, P. Suntharasamai, and N. J. White. 1998. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. J. Infect. Dis. 178: 520-525.
10. Kumaratilake, L. M., A. Ferrante, and C. M. Rzepczyk. 1990. Tumour necrosis factor enhances neutrophils mediated killing of Plasmodium falciparum. Infect. Immun. 58: 788-791.
11. Maegraith, B., and A. Fletcher. 1972. The pathogenesis of mammalian malaria. Adv. Parasitol. 10: 49-75.
12. Finlay-Jones, J. J., K. V. Davies, L. P. Sturm, P. A. Kenny, and P. H. Hart. 1999. Inflammatory processes in a murine model of intra-abdominal abscess formation. J. Leukocyte Biol. 66: 583-587.
13. Zhang, Y., B. F. Ramos, and B. A. Jakschik. 1992. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258: 1957-1978.
14. Church, M. K., S. T. Holgate, J. K. Shute, A. F. Walls, and A. P. Sampson. 1998. Mast cell derived mediators. In Allergy: Principles & Practice. E. Middleton, C. E. Reed, E. F. Ellis, N. F. Adkinson, J. W. Yunginger, and W. W. Busse, eds. Mosby, St. Louis, pp. 146-167.
15. Gersch, C., O. Dewald, M. Zoerlein, L. H. Michael, M. L. Entman, and N. G. Frangogiannis. 2002. Mast cells and macrophages in normal C57/BL/6 mice. Histochem. Cell Biol. 118: 41-49.
16. Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli, and M. E. Dorf. 1989. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170: 245-357.
17. Galli, S. J., M. Maurer, and C. S. Lantz. 1999. Mast cells as sentinels of innate immunity. Curr. Opin. Immunol. 11: 53-59.
18. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346: 274-276.
19. Tedla, N., H. W. Wang, H. P. McNeil, N. Di Girolamo, T. Hampartzoumian, D. Wakefield, and A. Lloyd. 1998. Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1α and MIP-1β. J. Immunol. 161: 5663-5672.
20. Wang, H. W., N. Tedla, A. R. Lloyd, D. Wakefield, and P. H. McNeil. 1998. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 102: 1617-1626.
21. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381: 77-80.
22. McLachlan, J. B., J. P. Hart, S. V. Pizzo, C. P. Shelburne, H. F. Staats, M. D. Gunn, and S. N. Abraham. 2003. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nature Immunol. 4: 1199-1205.
23. Supajatura, V., H. Ushio, A. Nakao, K. Okumura, C. Ra, and H. Ogawa. 2001. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 167: 2250-2256.
24. Bradding, P., and S. T. Holgate. 1999. Immunopathology and human mast cell cytokines. Crit. Rev. Oncol. Hematol. 31: 119-133.
25. -/- mice. J. Immunol. 159: 1418-1428.
26. Janse, C. J., and A. P. Waters. 1995. Plasmodium berghei: the application of cultivation and purification techniques to molecular studies of malaria parasites. Parasitol. Today 11: 138-143.
27. Razin, E., J. N. Ihle, D. Seldin, J.-M. Mencia-Huerta, H. R. Katz, P. A. Leblanc, A. Hein, J. P. Caulfield, K. F. Austen, and R. L. Stevens. 1984. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132: 1479-1486.
28. Fast, D. J., P. M. Schlievert, and R. D. Nelson. 1989. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect. Immun. 57: 291-294.
29. Hogan, M. M., and S. N. Vogel. 1991. Measurements of tumor necrosis factor α and β. In Current Protocols in Immunology. J. E. Coligan, ed. John Wiley and Sons, Somers, pp. 6.10.1-6.10.5.
30. Watanabe, N., Y. Hayashi, A. Kobayashi, and H. Ohtomo. 1996. Brugia malayi infection in mice with selective suppression of IgE production. Int. Arch. Allergy Immunol. 109: 192-196.
31. Aridor, M., L. M. Traub, and R. Sagi-Eisenberg. 1990. Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins. J. Cell Biol. 111: 909-917.
32. v mice that are genetically deficient in mast cells. J. Exp. Med. 165: 615-627.
33. Dery, R. E., T.-J. Lin, A. D. Befus, C. D. Milne, R. Moqbel, G. Menard, and E. Y. Bissonnette. 2000. Redundancy or cell-type-specific regulation: tumor necrosis factor in alveolar macrophages and mast cells. Immunology 99: 427-434.
34. Taverne, J., N. Sheikh, J. B. De Souza, J. H. L. Playfair, L. Probert, and G. Kollias. 1994. Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology 82: 397-403.
35. Johnson, R. A., T. A. Waddelow, J. Caro, A. Oliff, and G. D. Roodman. 1989. Chronic exposure to tumour necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 74: 130-138.
36. Moldawer, L. L., M. A. Marano, H. Wei, Y. Fong, M. L. Silen, G. Kuo, K. R. Mahogue, H. Vlassara, H. Cohen, and A. Cerami. 1989. Cachectin/tumour necrosis factor-α alters red blood cell kinetics and induces anaemia in vivo. FASEB 3: 1637-1643.
37. Jhaveri, K. N., K. Ghosh, D. Mohanty, B. D. Parmar, R. R. Surati, H. M. Camoens, S. H. Joshi, Y. S. Iyer, A. Desai, and S. S. Badakere. 1997. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria. Natl. Med. J. India 10: 5-7.
38. Phanuphak, P., M. Hanvanich, R. Sakulramrung, P. Moollaor, V. Sitprija, and D. Phanthumkosol. 1985. Complement changes in falciparum malaria infection. Clin. Exp. Immunol. 59: 571-576.
39. Siddique, M. E., and S. Ahmed. 1995. Serum complement C4 levels during acute malarial infection and post-treatment period. Indian J. Pathol. Microbiol. 38: 335-339.
40. Wenisch, C., S. Spitzauer, K. Florris-Linau, H. Rumpold, S. Vannaphan, B. Parschalk, W. Graninger, and S. Looareesuwan. 1997. Complement activation in severe Plasmodium falciparum malaria. Clin. Immunol. Immunopathol. 85: 166-167.
41. Seitz, H. M. 1972. Demonstration of malarial antigens in the sera of Plasmodium berghei-infected mice. J. Parasitol. 58: 179-180.
42. June, C. H., C. E. Contreras, L. H. Perrin, P. H. Lambert, and P. A. Miescher. 1979. Circulating and tissue-bound immune complex formation in murine malaria. J. Immunol. 122: 2154-2161.
43. Adam, C., M. Geniteau, M. Gougerot-Pocidalo, P. Verroust, J. Lebras, C. Gibert, and L. Morel-Maroger. 1981. Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria. Infect. Immun. 31: 530-435.
44. Abdalla, S., and D. J. Weatherall. 1982. The direct antiglobulin test in P. falciparum malaria. Br. J. Haematol. 51: 415-425.
45. Kawamoto, Y., K. Kojima, Y. Hitsumoto, H. Okada, M. Holers, and A. Miyama. 1997. The serum resistance of malaria-infected erythrocytes. Immunology 91: 7-12.
46. Stoute, J. A., A. O. Odindo, B. O. Owuor, E. K. Mibei, M. O. Opollo, and J. N. Waitumbi. 2003. Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia. J. Infect. Dis. 187: 522-525.
47. Hazenbos, W. L. W., J. E. Gessner, F. M. A. Hofhuis, H. Kuipers, D. Meyer, I. A. F. M. Heijnen, R. E. Schmidt, M. Sandor, P. J. A. Capel, M. Daëron, et al. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 5: 181-189.
48. Perlmann, H., H. Helmby, M. Hagstedt, J. Carlson, P. H. Larsson, M. Troye-Blomberg, and P. Parlmann. 1994. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin. Exp. Immunol. 97: 284-292.
49. Perlmann, P., H. Perlmann, G. Eighazali, and M. T. Blomberg. 1999. IgE and tumor necrosis factor in malaria infection. Immunol. Lett. 65: 29-33.
50. Galli, S. J., and S. Nakae. 2003. Mast cells to the defense. Nat. Immunol. 4: 1160-1162.
51. Mekori, Y. A., and D. D. Metcalfe. 1999. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 104: 517-523.
52. Bhattacharyya, S. P., I. Drucker, T. Reshef, A. S. Kirshenbaum, D. D. Metcalfe, and Y. A. Mekori. 1998. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J. Leukocyte Biol. 63: 337-341.
53. Inamura, N., Y. A. Mekori, S. P. Bhattacharyya, P. J. Bianchine, and D. D. Metcalfe. 1998. Induction and enhancement of FcεRI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J. Immunol. 160: 4026-4033.